Records containing: Lung Cancer (NSCLC)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-10-30Advance Care Planning Impact on the Consistency of Older Adults With Lung Cancer and Their Potential Surrogates Regarding Life-Sustaining Treatment Preferences
-
CLINICAL_TRIALS study record update · 2026-10-30Advance Care Planning Impact on the Consistency of Older Adults With Lung Cancer and Their Potential Surrogates Regarding Life-Sustaining Treatment Preferences
-
CLINICAL_TRIALS study record update · 2026-10-30Evaluation of a Routine Second Transurethral Resection of the Bladder (TURBT) After Primary Complete Blue Light TURBT in Patients With Non-muscle Invasive Intermediate- and High-risk Urothelial Bladder Cancer: a Prospective, Randomized, Multicenter Study
-
CLINICAL_TRIALS study record update · 2026-09-29First-in-Human, Phase 1 Study of PHN-012, an Antibody Drug Conjugate, in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-09-17Phase 1/1b, Multicenter, Open-Label, Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-09-15A Phase 1/2, Multicentre, Open-Label, Dose Escalation and Expansion Study to Assess the Safety, Pharmacokinetics, and Preliminary Efficacy of SL-28 in Patients With Advanced Solid Tumours
-
CLINICAL_TRIALS study record update · 2026-08-28Evaluation of the Distribution of CM500 in Healthy Volunteers and Patients With Cancer
-
CLINICAL_TRIALS study record update · 2026-04-27Multimodal CT-Based Risk Stratification of Postoperative Local Recurrence in Non-Small Cell Lung Cancer: A Multicenter Study
-
CLINICAL_TRIALS study record update · 2026-04-17Comprehensive Prospective Comparison Of Two Robotic Platforms In Anatomical Lung Resections: Clinical Outcomes And Cost-utility Analysis.
-
CLINICAL_TRIALS study record update · 2026-04-17First-in-Human, Phase 1 Study of PHN-012, an Antibody Drug Conjugate, in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-03-27Phase 1B Trial of Intratumoral Cisplatin for Stage IV Lung Cancer
-
CLINICAL_TRIALS study record update · 2026-03-24The Safety and Efficacy of Osimertinib Plus Capivasertib in EGFRm Advanced Non-small Cell Lung Cancer (NSCLC) Participants With PIK3CA/AKT1/PTEN Alterations Who Had Progressed on First-line Osimertinib Monotherapy or Plus Chemotherapy: a First-in-human, Phase Ib/Ⅱa Study (PRECISION)
-
CLINICAL_TRIALS study record update · 2026-03-23AN INTERVENTIONAL, OPEN-LABEL, PHASE 2 STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF PF-08634404 MONOTHERAPY OR IN COMBINATION IN ADULT PARTICIPANTS WITH EARLY-STAGE RESECTABLE OR LOCALLY ADVANCED UNRESECTABLE NON-SMALL CELL LUNG CANCER
-
CLINICAL_TRIALS study record update · 2026-03-20Magnetic Resonance Imaging of the Lung: Oncological Applications
-
CLINICAL_TRIALS study record update · 2026-03-20A Prospective, Multicenter Study on the Safety and Efficacy of Furmonertinib Combined With Local Chest Radiotherapy in EGFR+ Non-small Cell Lung Adenocarcinoma Patients With Malignant Pleural Effusion
-
CLINICAL_TRIALS study record update · 2026-03-18Immune Response to Immunotherapy in Lung Cancer: Study of Sputum and Blood Samples
-
CLINICAL_TRIALS study record update · 2026-03-16An Exploratory Phase II Clinical Study Protocol of Perioperative Treatment With Glesorasib Sequentially Combined With Ivonescimab and Chemotherapy for Resectable, Stage IB-IIIB, KRAS G12C-Mutant NSCLC
-
CLINICAL_TRIALS study record update · 2026-03-11A Study Protocol for Evaluating the Efficacy and Safety of Tunlametinib Combination Therapy in KRAS-Mutated Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer
-
CLINICAL_TRIALS study record update · 2026-03-09A Randomized, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Adjuvant Tislelizumab in High-Risk Stage I NSCLC
-
CLINICAL_TRIALS study record update · 2026-03-05PD-L1 Targeting Peptide Probe 68Ga-cPP-BCH for PET Imaging of Solid Tumor
-
CLINICAL_TRIALS study record update · 2026-03-05Practical Geriatric Assessment in Older Adults With Non-Small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy
-
CLINICAL_TRIALS study record update · 2026-03-04Phase II Trial of Perioperative Cemiplimab in Patients With Resectable Non-small Cell Lung Cancer and PD-L1 ≥50%
-
CLINICAL_TRIALS study record update · 2026-03-03Engagement of Veterans With Lung Cancer (EVLC)
-
CLINICAL_TRIALS study record update · 2026-03-02Efficacy and Safety of Pemetrexed Combined With Bevacizumab Intrathecal Injection in Patients With Leptomeningeal Metastases in NSCLC
-
CLINICAL_TRIALS study record update · 2026-02-27Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer